Multiple Myeloma Coverage from Every Angle

Sagar Lonial, MD, on Multiple Myeloma: Upfront, Relapsed, and Transplant Options

Posted: Wednesday, August 8, 2018

Sagar Lonial, MD, of the Emory University School of Medicine, discusses the conditions, such as lab results or previous drug-related reactions, that raise red flags when selecting treatment options for first-line and later lines of therapy in multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.